User login
Review the PDF of the fact sheet on biologics for psoriasis with board-relevant, easy-to-review material. This month's fact sheet discusses the current US Food and Drug Administration–approved biologic medications for psoriasis and psoriatic arthritis, including the mechanism of action, dosing, and side effects.
Practice Questions
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
Answers to practice questions provided on next page
Practice Question Answers
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
Review the PDF of the fact sheet on biologics for psoriasis with board-relevant, easy-to-review material. This month's fact sheet discusses the current US Food and Drug Administration–approved biologic medications for psoriasis and psoriatic arthritis, including the mechanism of action, dosing, and side effects.
Practice Questions
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
Answers to practice questions provided on next page
Practice Question Answers
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
Review the PDF of the fact sheet on biologics for psoriasis with board-relevant, easy-to-review material. This month's fact sheet discusses the current US Food and Drug Administration–approved biologic medications for psoriasis and psoriatic arthritis, including the mechanism of action, dosing, and side effects.
Practice Questions
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
Answers to practice questions provided on next page
Practice Question Answers
1. Which biologic is administered as an intravenous infusion?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
3. Which biologic has been shown to worsen existing Crohn disease?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
4. Which biologic is a fusion protein?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?
a. adalimumab
b. etanercept
c. infliximab
d. secukinumab
e. ustekinumab
